Preclinical testing in the development of probiotics: a regulatory perspective with Bacillus strains as an example

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Iryna Sorokulova

Abstract

Preclinical testing of the microbial strains is the first important step in the development of probiotics. Requirements for the set of tests can vary depending on the bacterial species and the expected mechanism of action in the organism. Common approaches to preclinical testing of probiotic strains include strain identification (i.e., determination of phenotypic and genotypic properties), safety evaluation (i.e., characterization of history of use [safety contact], assessment of resistance to antibiotics, and evaluation of pathogenic properties in vitro and in animal models), and efficacy testing (i.e., functional characterization). Future progress in probiotics requires more studies to determine the mechanisms of their action, as well as an understanding of the basis and mechanisms of pathogenicity for different probiotic strains. Special attention should be given to recombinant probiotics, particularly in the formulation of criteria for selection of the host strain, for assessment of environmental safety, and for tracing the fate of recombinant DNA in vitro and in vivo.

References

Jan 1, 1978·Zeitschrift für allgemeine Mikrobiologie·S P Chattopadhyay, A K Banerjee
Apr 1, 1995·International Journal of Systematic Bacteriology·O N RevaV V Smirnov
Nov 17, 1998·Journal of Travel Medicine·I B SorokulovaI V Pinchuk
Mar 13, 1999·Journal of Clinical Microbiology·G Y HaY Chong
Feb 7, 2001·The American Journal of Clinical Nutrition·N Ishibashi, S Yamazaki
Apr 17, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B Lund, C Edlund
May 11, 2002·Research in Microbiology·Giovanna CaldiniGiovanni Cenci
Nov 9, 2002·International Journal of Food Microbiology·R TemmermanJ Swings
Nov 22, 2002·Trends in Biotechnology·Jos F M L Seegers
Jan 1, 1964·The Journal of Pathology and Bacteriology·W SIMS
Nov 25, 2003·Journal of Applied Microbiology·S SalvettiS Senesi
Dec 3, 2004·The Journal of Antimicrobial Chemotherapy·C MoubareckF Doucet-Populaire
Jan 11, 2005·Current Pharmaceutical Design·Gregor Reid, UNKNOWN Food and Agricultural Organization of the United Nation and the WHO
Mar 8, 2005·The Pediatric Infectious Disease Journal·Mary Ann De GrooteNorman R Pace
Aug 17, 2005·FEMS Microbiology Reviews·Huynh A HongSimon M Cutting
Nov 5, 2005·International Journal of Food Microbiology·Ozkan AslantaşGülsüm A Evrendilek
Feb 8, 2006·Nature Reviews. Microbiology·Adrienne W PatonJames C Paton
Mar 21, 2006·Journal of Bacteriology·Nguyen K M TamSimon M Cutting
Nov 1, 2006·Antimicrobial Agents and Chemotherapy·Linda M WeigelJean B Patel

❮ Previous
Next ❯

Citations

Jul 4, 2012·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Benoît FolignéBruno Pot
Apr 27, 2010·Current Opinion in Biotechnology·I JankovicA Mercenier
Feb 22, 2012·Beneficial Microbes·J BaderU Stahl
Jul 23, 2013·Current Opinion in Microbiology·Benoit FolignéBruno Pot
Sep 28, 2013·International Journal of Antimicrobial Agents·Hanna Sikorska, Wanda Smoragiewicz
Apr 19, 2017·Antimicrobial Agents and Chemotherapy·Darya StarosilaIryna Sorokulova
Jul 29, 2010·Nature Reviews. Gastroenterology & Hepatology·Mélanie G GareauW Allan Walker
Feb 18, 2011·Gut Microbes·Mary Ellen SandersElaine Vaughan
Mar 9, 2017·World Journal of Microbiology & Biotechnology·Abdelhamid A HamdyMona A Esawy
Jan 30, 2021·Frontiers in Microbiology·Elena FeketeAndre G Buret

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The British Journal of Nutrition
Łukasz GrześkowiakMiguel Gueimonde
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
David R Snydman
Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition
Benoît FolignéBruno Pot
Proceedings of the National Academy of Sciences of the United States of America
Peter van BaarlenMichiel Kleerebezem
© 2021 Meta ULC. All rights reserved